Pathogenesis of liver fibrosis.
暂无分享,去创建一个
[1] Scott L. Friedman,et al. Evolving challenges in hepatic fibrosis , 2010, Nature Reviews Gastroenterology &Hepatology.
[2] V. Reichenbach,et al. [Endogenous cannabinoids in liver disease: Many darts for a single target]. , 2010, Gastroenterologia y hepatologia.
[3] K. Iwaisako,et al. Hepatocytes do not undergo epithelial‐mesenchymal transition in liver fibrosis in mice , 2010, Hepatology.
[4] R. Wells. The epithelial‐to‐mesenchymal transition in liver fibrosis: Here today, gone tomorrow? , 2010, Hepatology.
[5] D. Mann,et al. NF-kappaB signalling: embracing complexity to achieve translation. , 2010, Journal of hepatology.
[6] W. Jiménez,et al. [Endogenous cannabinoids in liver disease: Many darts for a single target]. , 2010, Gastroenterologia y hepatologia.
[7] Natalie J Torok,et al. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. , 2010, American journal of physiology. Gastrointestinal and liver physiology.
[8] G. Szabo,et al. Emerging role of microRNAs in liver diseases. , 2009, World journal of gastroenterology.
[9] P. Angus,et al. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. , 2009, Clinical science.
[10] A. Diehl,et al. Epithelial‐to‐mesenchymal transitions in the liver , 2009, Hepatology.
[11] D. Bar-Sagi,et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. , 2009, The Journal of clinical investigation.
[12] Yoshinobu Sato,et al. Clinicopathological analysis of CD133+ and NCAM+ human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[13] E. Novo,et al. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis. , 2009, The international journal of biochemistry & cell biology.
[14] J. Sicklick,et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[15] J. Iredale,et al. Reversibility of liver fibrosis. , 2009, Annals of hepatology.
[16] Y. Inagaki,et al. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. , 2009, Gastroenterology.
[17] D. Schuppan,et al. Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies , 2009, Hepatology.
[18] F. Marra,et al. Adipokines in liver diseases , 2009, Hepatology.
[19] D. Brenner,et al. Angiotensin‐converting‐enzyme 2 inhibits liver fibrosis in mice , 2009, Hepatology.
[20] T. Cheng,et al. Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways , 2009, The FEBS journal.
[21] B. Gao,et al. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases , 2009, Journal of leukocyte biology.
[22] M. Fujimiya,et al. Pathological roles of bone marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[23] V. Serre-Beinier,et al. Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver , 2009, PloS one.
[24] J. Mann,et al. Transcriptional regulation of hepatic stellate cells. , 2009, Advanced drug delivery reviews.
[25] D. Rockey,et al. Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[26] R. Schwabe,et al. CCR1 and CCR5 promote hepatic fibrosis in mice. , 2009, The Journal of clinical investigation.
[27] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[28] R. Bataller,et al. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. , 2009, Gastroenterology.
[29] W. Jeong,et al. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride , 2009, Hepatology.
[30] Olivia T. Abar,et al. Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses , 2009, Hepatology.
[31] Jaume Bosch,et al. Angiogenesis in liver disease. , 2009, Journal of hepatology.
[32] J. Fallowfield,et al. Senescence of activated stellate cells: Not just early retirement , 2009, Hepatology.
[33] J. Dranoff,et al. Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression. , 2009, Cell calcium.
[34] R. Gregory,et al. Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.
[35] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[36] Guangcun Huang,et al. Over‐expressed microRNA‐27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation , 2009, FEBS letters.
[37] D. Brenner,et al. NK and NKT cells in liver injury and fibrosis. , 2009, Clinical immunology.
[38] C. Hellerbrand,et al. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. , 2008, Biochemical and biophysical research communications.
[39] R. Bataller,et al. Cytokines and renin-angiotensin system signaling in hepatic fibrosis. , 2008, Clinics in liver disease.
[40] A. Burt,et al. Fibrosis and cirrhosis reversibility - molecular mechanisms. , 2008, Clinics in liver disease.
[41] D. Schuppan,et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. , 2008, The Journal of clinical investigation.
[42] S. Pol,et al. Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C , 2008, Annals of Internal Medicine.
[43] R. Kalluri,et al. The role of endothelial-to-mesenchymal transition in cancer progression , 2008, British Journal of Cancer.
[44] S. Friedman,et al. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis , 2008, Hepatology.
[45] S. Lowe,et al. Senescence of Activated Stellate Cells Limits Liver Fibrosis , 2008, Cell.
[46] S. Glaser,et al. Leptin enhances cholangiocarcinoma cell growth. , 2008, Cancer research.
[47] B. Garmy-Susini,et al. Integrins in angiogenesis and lymphangiogenesis , 2008, Nature Reviews Cancer.
[48] S. Friedman,et al. Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.
[49] Y. Inagaki,et al. Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7. , 2008, Gastroenterology.
[50] R. Hay,et al. NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. , 2008, Journal of hepatology.
[51] D. Schuppan,et al. The hedgehog pathway regulates remodelling responses to biliary obstruction in rats , 2008, Gut.
[52] Jianguo Lin,et al. Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells , 2008, Laboratory Investigation.
[53] H. Friess,et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. , 2008, Journal of hepatology.
[54] J. Mann,et al. Epigenetic regulation of hepatic stellate cell activation , 2008, Journal of gastroenterology and hepatology.
[55] D. Brenner,et al. High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate–activated protein kinase , 2008, Hepatology.
[56] F. Marra,et al. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. , 2008, Molecular aspects of medicine.
[57] M. Pekalski,et al. Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease , 2008, Laboratory Investigation.
[58] R. Schwabe,et al. Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[59] Zhigang Tian,et al. Liver: An organ with predominant innate immunity , 2007, Hepatology.
[60] Ji Won Kim,et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. , 2008, Human pathology.
[61] S. Friedman. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.
[62] Y. Kloog,et al. The Effect of Ras Inhibition on the Proliferation, Apoptosis and Matrix Metalloproteases Activity in Rat Hepatic Stellate Cells , 2008, Digestive Diseases and Sciences.
[63] M. Buck,et al. A Ribosomal S-6 Kinase–Mediated Signal to C/EBP-β Is Critical for the Development of Liver Fibrosis , 2007, PloS one.
[64] E. Olson,et al. MEF2: a central regulator of diverse developmental programs , 2007, Development.
[65] A. Dolganiuc,et al. Innate immune response and hepatic inflammation. , 2007, Seminars in liver disease.
[66] I. Leclercq,et al. ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride–induced hepatic fibrosis in mice , 2007, Hepatology.
[67] D. A. Gomes,et al. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll‐like receptor 9 , 2007, Hepatology.
[68] Yosuke Osawa,et al. TLR4 enhances TGF-β signaling and hepatic fibrosis , 2007, Nature Medicine.
[69] W. Jeong,et al. Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[70] R. Kalluri,et al. Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition* , 2007, Journal of Biological Chemistry.
[71] A. Elsharkawy,et al. Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis , 2007 .
[72] Olivia T. Abar,et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C , 2007, Hepatology.
[73] S. Terai,et al. Importance of inhibitor of DNA binding/differentiation 2 in hepatic stellate cell differentiation and proliferation , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[74] D. Stupack. The biology of integrins. , 2007, Oncology.
[75] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[76] Connie Wang,et al. Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro* , 2007, Journal of Biological Chemistry.
[77] T. Liang,et al. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma , 2007, Journal of Cancer Research and Clinical Oncology.
[78] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[79] F. Marra,et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. , 2007, The American journal of pathology.
[80] A. Gressner,et al. Pro-fibrogenic potential of PDGF-D in liver fibrosis. , 2007, Journal of hepatology.
[81] Y. Takei,et al. Role of adipocytokines in hepatic fibrogenesis , 2007, Journal of gastroenterology and hepatology.
[82] J. Fallowfield,et al. Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis1 , 2007, The Journal of Immunology.
[83] Shoana L. Sikorski,et al. Regulation of Hepatic Stellate Cell Differentiation by the Neurotrophin Receptor p75NTR , 2007, Science.
[84] Albert Bendelac,et al. The biology of NKT cells. , 2007, Annual review of immunology.
[85] Didier Merlin,et al. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. , 2007, Cancer research.
[86] J. Iredale,et al. Liver fibrosis: cellular mechanisms of progression and resolution. , 2007, Clinical science.
[87] A. Mallat,et al. Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases , 2007, Expert opinion on therapeutic targets.
[88] Y. Inagaki,et al. Emerging insights into Transforming growth factor β Smad signal in hepatic fibrogenesis , 2007, Gut.
[89] A. Thorne,et al. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis , 2007, Cell Death and Differentiation.
[90] R. Kalluri,et al. Transcriptional regulation of epithelial-mesenchymal transition. , 2007, The Journal of clinical investigation.
[91] H. Okano,et al. Bone marrow–derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice , 2007, Hepatology.
[92] W. Pu,et al. Zeisberg, E.M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961 , 2007 .
[93] S. Friedman,et al. The Role of Inflammation and Immunity in the Pathogenesis of Liver Fibrosis , 2007 .
[94] F. Marra. Leptin and liver tissue repair: do rodent models provide the answers? , 2007, Journal of hepatology.
[95] Nils Cordes,et al. Signalling via integrins: implications for cell survival and anticancer strategies. , 2007, Biochimica et biophysica acta.
[96] J. Dranoff,et al. Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[97] W. Jeong,et al. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity , 2006, Hepatology.
[98] C. Lechuga,et al. PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[99] S. Romagnani. Regulation of the T cell response , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[100] S. Sheikh,et al. In Vitro and In Vivo Protection of Stellate Cells from Apoptosis by Leptin , 2006, Digestive Diseases and Sciences.
[101] Christopher J. Parsons,et al. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. , 2006, Journal of hepatology.
[102] M. Fraga,et al. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells. , 2006, Biochemical and biophysical research communications.
[103] C. J. Marek,et al. Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. , 2006, Gastroenterology.
[104] S. Friedman,et al. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. , 2006, Journal of hepatology.
[105] C. Ledent,et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis , 2006, Nature Medicine.
[106] Youhua Liu,et al. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. , 2006, The American journal of pathology.
[107] S. Dooley,et al. Id1 is a critical mediator in TGF‐β–induced transdifferentiation of rat hepatic stellate cells , 2006, Hepatology.
[108] S. Forbes,et al. The bone marrow functionally contributes to liver fibrosis. , 2006, Gastroenterology.
[109] R. Wells,et al. Increased ADAMTS‐13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo , 2006, Journal of thrombosis and haemostasis : JTH.
[110] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[111] A. P. Holt,et al. Attenuated liver fibrosis in the absence of B cells , 2006, Hepatology.
[112] Raghu Kalluri,et al. The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.
[113] R. Sun,et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.
[114] S. Friedman,et al. Reversal of hepatic fibrosis — Fact or fantasy? , 2006, Hepatology.
[115] F. Marra,et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans , 2005, Gut.
[116] Vinay Tergaonkar,et al. NFκB pathway: A good signaling paradigm and therapeutic target , 2006 .
[117] S. Dooley,et al. TGF-β/Smad Signaling in the Injured Liver , 2006 .
[118] S. Milani,et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells , 2005, Hepatology.
[119] B. Luxon,et al. Rat hepatic stellate cells become retinoid unresponsive during activation. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.
[120] H. Tsukamoto. Adipogenic phenotype of hepatic stellate cells. , 2005, Alcoholism, clinical and experimental research.
[121] S. Shukla,et al. Histone h3 modifications in rat hepatic stellate cells by ethanol. , 2005, Alcohol and alcoholism.
[122] Jiri Zavadil,et al. TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.
[123] D. Brenner,et al. Liver fibrogenesis: a new role for the renin-angiotensin system. , 2005, Antioxidants & redox signaling.
[124] A. Morelli,et al. A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis , 2005, Journal of Pharmacology and Experimental Therapeutics.
[125] F. Anania,et al. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. , 2005, The American journal of pathology.
[126] Sang -Geon Kim,et al. meso-Dihydroguaiaretic Acid from Machilus thunbergii Down-Regulates TGF-β1 Gene Expression in Activated Hepatic Stellate Cells via Inhibition of AP-1 Activity , 2005, Planta medica.
[127] Toshikazu Nakamura,et al. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. , 2005, The American journal of pathology.
[128] B. Gao,et al. Cytokines, STATs and liver disease. , 2005, Cellular & molecular immunology.
[129] Liying Li,et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. , 2005, Gastroenterology.
[130] S. Forbes,et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.
[131] D. Brenner,et al. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury , 2004, Gut.
[132] B. Staels,et al. The Farnesoid X Receptor (FXR) as Modulator of Bile Acid Metabolism , 2004, Reviews in Endocrine and Metabolic Disorders.
[133] Q. Tang,et al. Involvement of C/EBP-α gene in in vitro activation of rat hepatic stellate cells , 2004 .
[134] S. Friedman,et al. Lhx2-/- mice develop liver fibrosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[135] A. Morelli,et al. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. , 2004, Gastroenterology.
[136] S. Friedman,et al. Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2. , 2004, Gastroenterology.
[137] F. Anania,et al. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[138] J. Fallowfield,et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. , 2004, Gastroenterology.
[139] M. Rugge,et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. , 2004, Gastroenterology.
[140] R. Rippe,et al. Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells* , 2004, Journal of Biological Chemistry.
[141] K. Mak,et al. Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells , 2004, Journal of Biological Chemistry.
[142] William R. Sellers,et al. PI3K/PTEN/Akt Pathway , 2004 .
[143] C. Vinson,et al. Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[144] R. Kalluri,et al. Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.
[145] F. Tülübaş,et al. Protective effect of IGF-1 on experimental liver cirrhosis-induced common bile duct ligation. , 2003, Hepato-gastroenterology.
[146] R. Schwabe,et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. , 2003, The Journal of clinical investigation.
[147] W. Mckeehan,et al. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. , 2003, The American journal of pathology.
[148] H. Yoshiji,et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis , 2003, Gut.
[149] G. Weinmaster,et al. Basal Expression of IκBα Is Controlled by the Mammalian Transcriptional Repressor RBP-J (CBF1) and Its Activator Notch1* , 2003, Journal of Biological Chemistry.
[150] R. Kalluri,et al. BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.
[151] R. Bataller,et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. , 2003, Gastroenterology.
[152] Jianye Xu,et al. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[153] Christian Jobin,et al. Toll‐Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells , 2003, Hepatology.
[154] R. Groszmann,et al. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[155] D. Rockey. Vascular mediators in the injured liver , 2003, Hepatology.
[156] William R Sellers,et al. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. , 2003, Cancer treatment and research.
[157] F. Braet,et al. Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. , 2002, Journal of hepatology.
[158] F. Marra,et al. Chemokines in liver inflammation and fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.
[159] F. Lammert,et al. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. , 2002, Journal of hepatology.
[160] M. Pinzani. PDGF and signal transduction in hepatic stellate cells. , 2002, Frontiers in bioscience : a journal and virtual library.
[161] D. Mann,et al. Transcriptional regulation of hepatic stellate cell activation , 2002, Gut.
[162] D. Rockey,et al. Effects of endothelins on hepatic stellate cell synthesis of endothelin‐1 during hepatic wound healing , 2002, Journal of cellular physiology.
[163] Hsin C. Lin,et al. Discoidin Domain Receptor 2 Interacts with Src and Shc following Its Activation by Type I Collagen* , 2002, The Journal of Biological Chemistry.
[164] Y. Takei,et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. , 2002, Gastroenterology.
[165] F. Marra. Leptin and liver fibrosis: a matter of fat. , 2002, Gastroenterology.
[166] T. Thomas,et al. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension , 2002, Gut.
[167] John P. Iredale,et al. Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.
[168] S. Friedman,et al. Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2* , 2002, The Journal of Biological Chemistry.
[169] A. Branch,et al. Elevated Expression of Tyrosine Kinase DDR2 in Primary Biliary Cirrhosis , 2002, Autoimmunity.
[170] T. Roskams,et al. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. , 2001, Journal of hepatology.
[171] S. Friedman,et al. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.
[172] M. Arthur,et al. Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells , 2001, Gut.
[173] J. Maher. Interactions between Hepatic Stellate Cells and the Immune System , 2001, Seminars in liver disease.
[174] D. Rockey. Cellular pathophysiology of portal hypertension and prospects for management with gene therapy. , 2001, Clinics in liver disease.
[175] A Geerts,et al. History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.
[176] D. Schuppan,et al. Matrix as a modulator of hepatic fibrogenesis. , 2001, Seminars in liver disease.
[177] J. Goergen,et al. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism , 2001, EMBO reports.
[178] M. Serio,et al. Signal Transduction by the Chemokine Receptor CXCR3 , 2001, The Journal of Biological Chemistry.
[179] V. Desmet,et al. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. , 2001, Hepatology.
[180] H. Ikeda,et al. Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. , 2000, Biochemical and biophysical research communications.
[181] J. Iredale,et al. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. , 2000, Histology and histopathology.
[182] A. Rivas-Estilla,et al. Tumor necrosis factor α down‐regulates expression of the α1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPβ‐ and C/EBPδ‐dependent mechanism , 2000 .
[183] S. Afford,et al. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. , 2000, The American journal of pathology.
[184] A. Desmoulière,et al. Deactivation of cultured human liver myofibroblasts by Trans‐resveratrol, a grapevine‐derived polyphenol , 2000, Hepatology.
[185] A. Rivas-Estilla,et al. Hydrogen peroxide: A link between acetaldehyde‐elicited α1(i) collagen gene up‐regulation and oxidative stress in mouse hepatic stellate cells , 2000, Hepatology.
[186] M. Arthur,et al. Persistent activation of nuclear factor‐κB in cultured rat hepatic stellate cells involves the induction of potentially novel rel‐like factors and prolonged changes in the expression of IκB family proteins , 1999, Hepatology.
[187] A. Mallat,et al. Biological Effects of C-type Natriuretic Peptide in Human Myofibroblastic Hepatic Stellate Cells* , 1999, The Journal of Biological Chemistry.
[188] R. Bataller,et al. Atrial natriuretic peptide antagonizes endothelin‐induced calcium increase and cell contraction in cultured human hepatic stellate cells , 1999, Hepatology.
[189] H. Yee,et al. Quantitation of rat hepatic stellate cell contraction: stellate cells' contribution to sinusoidal resistance. , 1999, The American journal of physiology.
[190] D. Schuppan,et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture , 1999, Hepatology.
[191] D. Rockey,et al. Regulation of Endothelin-1 Synthesis by Endothelin-converting Enzyme-1 during Wound Healing* , 1999, The Journal of Biological Chemistry.
[192] G. Ramadori,et al. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1 , 1999 .
[193] S. Eichhorst,et al. Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. , 1999, The American journal of pathology.
[194] D. Rockey,et al. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[195] Patrick P.L. Tam,et al. SOX9 directly regulates the type-ll collagen gene , 1997, Nature Genetics.
[196] H. Tsukamoto,et al. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. , 1997, The American journal of physiology.
[197] T. Ueno,et al. Intralobular innervation and lipocyte contractility in the liver. , 1997, Nutrition.
[198] J. Iredale. Tissue inhibitors of metalloproteinases in liver fibrosis. , 1997, The international journal of biochemistry & cell biology.
[199] D. Beno,et al. Suppression of Stellate Cell Type I Collagen Gene Expression Involves AP-2 Transmodulation of Nuclear Factor-1-dependent Gene Transcription* , 1996, The Journal of Biological Chemistry.
[200] D. Brenner,et al. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells , 1996, Hepatology.
[201] R. Kalluri,et al. Possible mechanisms of renal fibrosis. , 1996, Contributions to nephrology.
[202] H. Herbst,et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. , 1996, The American journal of pathology.
[203] M. Suematsu,et al. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. , 1995, The Journal of clinical investigation.
[204] M. Pinzani. Induction of β-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture , 1995 .
[205] F. Anania,et al. Effects of acetaldehyde on nuclear protein binding to the nuclear factor I consensus sequence in the α2(I) collagen promoter , 1995 .
[206] Gressner Am. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. , 1995 .
[207] A. Gressner. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. , 1995, Journal of hepatology.
[208] S. Friedman,et al. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. , 1994, The Journal of clinical investigation.
[209] V. Carloni,et al. Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. , 1994, Gastroenterology.
[210] D. Rockey,et al. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[211] N. Kawada,et al. Eicosanoid-mediated contractility of hepatic stellate cells. , 1992, The Biochemical journal.
[212] L. Gesualdo,et al. Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. , 1992, The American journal of physiology.
[213] M. Arthur,et al. Wright's Liver and biliary disease : pathophysiology, diagnosis and management , 1992 .
[214] Sims De. Recent advances in pericyte biology--implications for health and disease. , 1991 .
[215] D. Sims. Recent advances in pericyte biology--implications for health and disease. , 1991, The Canadian journal of cardiology.
[216] L. Gesualdo,et al. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. , 1989, The Journal of clinical investigation.
[217] W. Thompson. The fibrogenic response to tissue damage , 1980 .
[218] V. Arroyo,et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis , 1980 .
[219] V. Arroyo,et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. , 1980, Gastroenterology.
[220] H. Popper,et al. Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.